Innovation

The research team includes, left to right, Bruno Scaglioni, PhD; Keith Obstein MD, MPH; James Martin, PhD; Claire Landewee, BS; Simone Calò, PhD; and Pietro Valdastri, PhD. (hoto by Susan Urmy)

VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies

A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.

New “DNA” podcast season explores how to harness change, ideas to improve business and medicine

Go to your favorite podcast channel right now to subscribe and listen to the first episode of Season 4!

Vanderbilt’s Ken Holroyd, MD, MBA, lead of the Brock Family Center for Applied Innovation, speaks during the recent Healthcare Artificial Intelligence Sessions. (photo by Erin O. Smith)

Academics, entrepreneurs gather for first annual AI event

Artificial intelligence experts from industry and from Vanderbilt gathered on the VUMC campus recently for the first annual Healthcare Artificial Intelligence Sessions, or HAIS 23, sponsored by the Brock Family Center.

What could be next? Preview DNA’s Season 4 exploring the future

Preview the trailer for Season 4 of the Vanderbilt Health DNA podcast series. Explore issues facing businesses across industries, and how VUMC is experimenting with and designing solutions for problems — old and new — by supporting smart people with visionary ideas. 

A probe-based system developed by a team at Vanderbilt University and Vanderbilt University Medical Center uses near-infrared autofluorescence to confirm the location of parathyroid tissue during surgery.

Study shows Vanderbilt-developed technology assists surgeons in identifying parathyroids

A team of surgeons and biomedical engineers have shown the use of probe-based near infrared autofluorescence technology helps confirm the identification of parathyroid glands during endocrine surgery

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

1 2 3 4 5